Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study will determine whether fish oil can reduce depression in people with multiple
sclerosis (MS) who are mild to moderately depressed and are currently taking antidepressant
medication.
Study hypothesis: Three months of fish oil supplementation will improve depression scores on
the Montgomery-Asberg depression rating scale (MADRS) or Beck Depression Inventory (BDI)
better than placebo.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)